Hillman R S, Henderson P A
J Clin Invest. 1969 Mar;48(3):454-60. doi: 10.1172/JCI106002.
The level of erythroid marrow production varies widely in different erythropoietic disorders. In part, this reflects the level of erythropoietin stimulation as determined by the severity of the anemia. However, iron supply plays an equally important role in the control of erythropoiesis. As demonstrated in normal individuals subjected to prolonged periods of phlebotomy-induced anemia, the erythroid marrow will increase production by as little as twice to as much as eight times normal, depending on the iron supply available from different iron pools. Whereas the iron delivered from normal reticuloendothelial stores or orally administered iron is sufficient for a marrow production response of only two to three times normal, the increased iron supply from nonviable red cells, hemolysis, or iron dextran infusions permits marrow production to rise acutely to levels of four to eight times normal.
在不同的红细胞生成障碍中,红系骨髓的生成水平差异很大。部分原因在于,这反映了由贫血严重程度所决定的促红细胞生成素刺激水平。然而,铁供应在红细胞生成的调控中同样起着重要作用。正如在经历长期放血诱导贫血的正常个体中所显示的那样,红系骨髓的产量会增加,少则为正常水平的两倍,多则达到正常水平的八倍,这取决于来自不同铁池的可用铁供应。从正常网状内皮细胞储存中释放的铁或口服铁仅足以使骨髓产量产生正常水平两到三倍的反应,而来自无活力红细胞、溶血或右旋糖酐铁输注的铁供应增加,则可使骨髓产量急剧上升至正常水平的四到八倍。